MedPath

ATORVASTATIN CALCIUM

Approved
Approval ID

5f4b905e-588e-d760-e053-2991aa0ae134

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2017

Manufacturers
FDA

H.J Harkins Company Inc.

DUNS: 147681894

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ATORVASTATIN CALCIUM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76519-1063
Application NumberANDA091624
Product Classification
M
Marketing Category
C73584
G
Generic Name
ATORVASTATIN CALCIUM
Product Specifications
Route of AdministrationORAL
Effective DateDecember 1, 2017
FDA Product Classification

INGREDIENTS (1)

ATORVASTATIN CALCIUMActive
Quantity: 40 mg in 1 1
Code: 48A5M73Z4Q
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ATORVASTATIN CALCIUM - FDA Drug Approval Details